Paul A. Harmon

1.3k total citations
34 papers, 1.0k citations indexed

About

Paul A. Harmon is a scholar working on Organic Chemistry, Molecular Biology and Pharmaceutical Science. According to data from OpenAlex, Paul A. Harmon has authored 34 papers receiving a total of 1.0k indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Organic Chemistry, 8 papers in Molecular Biology and 8 papers in Pharmaceutical Science. Recurrent topics in Paul A. Harmon's work include Drug Solubulity and Delivery Systems (7 papers), Free Radicals and Antioxidants (6 papers) and Crystallization and Solubility Studies (4 papers). Paul A. Harmon is often cited by papers focused on Drug Solubulity and Delivery Systems (7 papers), Free Radicals and Antioxidants (6 papers) and Crystallization and Solubility Studies (4 papers). Paul A. Harmon collaborates with scholars based in United States and United Kingdom. Paul A. Harmon's co-authors include Sanford A. Asher, Robert A. Reed, Wei Xu, Junji Teraoka, Andrew S. Janoff, Allen C. Templeton, W. Peter Wuelfing, Hui Xu, Chad D. Brown and R. V. Plank and has published in prestigious journals such as Journal of the American Chemical Society, The Journal of Chemical Physics and Biochemistry.

In The Last Decade

Paul A. Harmon

34 papers receiving 962 citations

Author Peers

Peers are selected by citation overlap in the author's most active subfields. citations · hero ref

Author Last Decade Papers Cites
Paul A. Harmon 341 313 203 202 145 34 1.0k
Gábor Vasvári 262 0.8× 216 0.7× 115 0.6× 216 1.1× 83 0.6× 49 929
I. V. Terekhova 427 1.3× 372 1.2× 399 2.0× 319 1.6× 76 0.5× 110 1.3k
Tamaki Miyazaki 390 1.1× 151 0.5× 286 1.4× 162 0.8× 75 0.5× 42 793
Shigeo Kojima 559 1.6× 463 1.5× 488 2.4× 253 1.3× 99 0.7× 64 1.5k
John H. Coates 155 0.5× 444 1.4× 268 1.3× 310 1.5× 56 0.4× 54 1.1k
Wigand Hübner 74 0.2× 759 2.4× 92 0.5× 120 0.6× 81 0.6× 24 1.2k
Shuji Noguchi 355 1.0× 457 1.5× 340 1.7× 109 0.5× 44 0.3× 97 1.2k
Aden Hodžić 118 0.3× 446 1.4× 228 1.1× 80 0.4× 39 0.3× 28 996
Tatsuyuki Yamamoto 72 0.2× 312 1.0× 90 0.4× 105 0.5× 170 1.2× 70 766
Erik Söderlind 482 1.4× 231 0.7× 150 0.7× 129 0.6× 93 0.6× 22 1.0k

Countries citing papers authored by Paul A. Harmon

Since Specialization
Citations

This map shows the geographic impact of Paul A. Harmon's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Paul A. Harmon with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Paul A. Harmon more than expected).

Fields of papers citing papers by Paul A. Harmon

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Paul A. Harmon. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Paul A. Harmon. The network helps show where Paul A. Harmon may publish in the future.

Co-authorship network of co-authors of Paul A. Harmon

This figure shows the co-authorship network connecting the top 25 collaborators of Paul A. Harmon. A scholar is included among the top collaborators of Paul A. Harmon based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Paul A. Harmon. Paul A. Harmon is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Harmon, Paul A.. (2022). Ranitidine: A Proposed Mechanistic Rationale for NDMA Formation and a Potential Control Strategy. Journal of Pharmaceutical Sciences. 112(5). 1220–1224. 8 indexed citations
2.
Kesisoglou, Filippos, et al.. (2019). Effect of Amorphous Nanoparticle Size on Bioavailability of Anacetrapib in Dogs. Journal of Pharmaceutical Sciences. 108(9). 2917–2925. 68 indexed citations
3.
Nanda, Kausik K., et al.. (2017). Iron(III)-Mediated Oxidative Degradation on the Benzylic Carbon of Drug Molecules in the Absence of Initiating Peroxides. Journal of Pharmaceutical Sciences. 106(5). 1347–1354. 8 indexed citations
4.
5.
Pitzenberger, Steven M., et al.. (2013). Direct Evidence of 2-Cyano-2-Propoxy Radical Activity During AIBN-Based Oxidative Stress Testing in Acetonitrile–Water Solvent Systems. Journal of Pharmaceutical Sciences. 102(5). 1554–1568. 12 indexed citations
6.
Nelson, Eric D., et al.. (2008). Solvent Effects on the AIBN Forced Degradation of Cumene: Implications for Forced Degradation Practices. Journal of Pharmaceutical Sciences. 98(3). 959–969. 18 indexed citations
7.
Peresypkin, Andrey, Narayan Variankaval, Robert M. Wenslow, et al.. (2008). Discovery of a Stable Molecular Complex of an API With HCl: A Long Journey to a Conventional Salt. Journal of Pharmaceutical Sciences. 97(9). 3721–3726. 6 indexed citations
8.
Bai, Ge, et al.. (2007). Hydrodynamic Investigation of USP Dissolution Test Apparatus II. Journal of Pharmaceutical Sciences. 96(9). 2327–2349. 93 indexed citations
9.
Harmon, Paul A., Kathryn M. Kosuda, Eric D. Nelson, Mark D. Mowery, & Robert A. Reed. (2006). A Novel peroxy Radical Based Oxidative Stressing System for Ranking the Oxidizability of Drug Substances. Journal of Pharmaceutical Sciences. 95(9). 2014–2028. 40 indexed citations
10.
Harmon, Paul A., et al.. (2006). Evaluation of Hydroperoxides in Common Pharmaceutical Excipients. Journal of Pharmaceutical Sciences. 96(1). 106–116. 138 indexed citations
11.
Nelson, Eric D., et al.. (2006). Evaluation of Solution Oxygenation Requirements for Azonitrile-Based Oxidative Forced Degradation Studies of Pharmaceutical Compounds. Journal of Pharmaceutical Sciences. 95(7). 1527–1539. 22 indexed citations
12.
Harmon, Paul A., et al.. (2005). Mechanism of the Solution Oxidation of Rofecoxib Under Alkaline Conditions. Pharmaceutical Research. 22(10). 1716–1726. 8 indexed citations
13.
Beasley, Christopher A., Zhongxi Zhao, Paul A. Harmon, et al.. (2004). Identification and quantitation of extractables from cellulose acetate butyrate (CAB) and estimation of their in vivo exposure levels. Journal of Pharmaceutical and Biomedical Analysis. 35(4). 779–788. 4 indexed citations
14.
Harmon, Paul A., et al.. (2001). Purification and identification of an impurity in bulk hydrochlorothiazide. Journal of Pharmaceutical Sciences. 90(11). 1800–1809. 17 indexed citations
15.
16.
Perkins, Walter R., Xingong Li, James L. Slater, et al.. (1997). Solute-induced shift of phase transition temperature in Di-saturated PC liposomes: adoption of ripple phase creates osmotic stress. Biochimica et Biophysica Acta (BBA) - Biomembranes. 1327(1). 41–51. 15 indexed citations
17.
Harmon, Paul A., et al.. (1997). The Release and Detection of Endotoxin from Liposomes. Analytical Biochemistry. 250(2). 139–146. 32 indexed citations
18.
Sharma, Amarnath, E. Mayhew, Lois E. Bolcsak, et al.. (1997). Activity of paclitaxel liposome formulations against human ovarian tumor xenografts. International Journal of Cancer. 71(1). 103–107. 112 indexed citations
19.
Harmon, Paul A., et al.. (1995). Combination of Potentiometry and Resonance Raman Spectroscopy for the Analysis of a Redox Protein. Analytical Biochemistry. 224(1). 309–314. 2 indexed citations
20.
Harmon, Paul A., Richard W. Hendler, & Ira W. Levin. (1994). Resonance Raman and optical spectroscopic monitoring of heme a redox states in cytochrome c oxidase during potentiometric titrations. Biochemistry. 33(3). 699–707. 12 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Gábor Vasvári Breakdown of academic impact, for papers by I. V. Terekhova Breakdown of academic impact, for papers by Tamaki Miyazaki Breakdown of academic impact, for papers by Shigeo Kojima Breakdown of academic impact, for papers by John H. Coates Breakdown of academic impact, for papers by Wigand Hübner Breakdown of academic impact, for papers by Shuji Noguchi Breakdown of academic impact, for papers by Aden Hodžić Breakdown of academic impact, for papers by Tatsuyuki Yamamoto Breakdown of academic impact, for papers by Erik Söderlind
Rankless by CCL
2026